Document:

Amended and Restated Service Agreement, Peter Mitchell

 Exhibit 10.10 
 Execution Copy 
 Amended and Restated Service Agreement 

September     , 2012 
 Fleetmatics Irl Limited 
 and 

Peter Mitchell 

 Execution Copy 

 

 This Agreement is made the     day of September 2012 

Between 
  

	(1)	Fleetmatics Irl Limited, a company incorporated under the laws of Ireland under registration number 392887 having its registered office at Penthouse Suite, Block
C, Cookstown Court, Belgard Road, Tallaght, Dublin 24 (the “Company”); and 

  

	(2)	Peter Mitchell of Apartment 105, Block A, Smithfield Market, Smithfield, Dublin 7 (the “Appointee”) 

together, the “Parties” and each, a “Party”. 
 Recital: 
 A service agreement was entered into between the Parties on 1 December 2004
(the “Service Agreement”). This Agreement constitutes the entire amended and restated Service Agreement and supersedes in its entirety all prior undertakings and agreements between the Parties with respect to the subject matter
hereof. 
 Now it is hereby agreed as follows: 
  

	1	Definitions and Interpretation 

  

	1.1	In this Agreement: 

  

			
	“Associated Company”	  	means any company which is for the time being either a subsidiary company or a holding company (as defined by section 155 of the Companies Act, 1963, as amended) of the Company
or another subsidiary of any such holding company or a company having an equity share capital (as defined by section 155(5) of the Companies Act, 1963, as amended) of which not less than 25 per cent is controlled directly or indirectly by the
Company or its holding company or a company being controlled by any person or persons who control the Company (or a subsidiary of any such company) and the provisions of section 432 of the Taxes Consolidation Act 1997 will apply in the determination
of “control” for all purposes;
		
	“Board”	  	means the Company’s board of directors for the time being and includes any committee of the Company’s board of directors duly appointed by it from time to
time;
		
	“Businesses”	  	 means all and any trades or other commercial activities:

 
 (a)    which the Company
or any Associated Company will carry on with a view to profit and with which the Appointee will have been concerned or involved to any material extent at any time during his employment under this Agreement;
or

  
 2 

 Execution Copy 

 

			
		  	 (b)    which the Company or any Associated Company will at the Termination Date have determined to carry
on with a view to profit in the immediate or foreseeable future and in relation to which the Appointee will at the Termination Date possess any Confidential Business Information;

		
	 “Cause”
	  	 means:
  

(a)    the Appointee’s proven gross misconduct that results in proven material injury to
the Company; or
  

(b)    the Appointee’s proven unauthorised use or disclosure of any proprietary
information or trade secrets of the Company or any other party to whom the Appointee owes an obligation of nondisclosure as a result of the Appointee’s relationship with the Company; or

 
 (c)    the
Appointee’s proven wilful breach of any material obligations under any material written agreement or covenant with the Company; or
  

(d)    the Appointee’s continued failure to substantially perform his material
employment duties after the Appointee has received a written demand of performance from the Company which specifically sets forth the factual basis for the Company’s belief that the Appointee has not substantially performed his material duties
and has failed to cure such non-performance to the Company’s satisfaction within fifteen (15) business days after receiving such notice; or
  

(e)    if the Appointee is guilty of any serious default or gross or scandalous misconduct in
connection with or affecting the business of the Company or any Associated Company to which he is required by the Agreement to render services; or
  

(f)     if the Appointee becomes bankrupt or enters into any arrangement with his
creditors; or

  
 3 

 Execution Copy 

 

			
		  	 (g)    if the Appointee is convicted of any arrestable criminal offence
for which a custodial sentence may be imposed (other than an offence under road traffic legislation in Ireland or elsewhere for which a fine or non­custodial penalty is imposed); or

 
 (h)    if the Appointee
is disqualified from holding office in another company in which he is concerned or interested because of wrongful trading under the Companies Act, 1990; or
  

(i)     if the Appointee is convicted of an offence under Part V of the Companies Act,
1990 or under any other present or future statutory enactment or regulations relating to insider dealings;

		
	 “Change of Control”
	  	 means:
  

(a)    any person, who is not a direct or indirect shareholder of the Company as of the
Commencement Date or an affiliate thereof, becoming the beneficial owner, directly or indirectly, of securities of the Company representing 50% or more of the total voting power represented by the Company’s then outstanding voting securities;
or
  
 (b)    a
change in the composition of the Board occurring within a two-year period, as a result of which less than a majority of the directors are Incumbent Directors. “Incumbent Directors” will mean directors who either (A) are directors of the
Company as of the Commencement Date, or (B) are elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the remaining Incumbent Directors at the time of such election or nomination (but will not include
an individual whose election or nomination is in connection with an actual or threatened proxy contest relating to the election of directors to the Company); or
  

(c)    the date of the consummation of a merger, scheme of arrangement or consolidation of
the Company or the Company’s ultimate holding company with any other corporation that has been

  
 4 

 Execution Copy 

 

			
		  	 approved by the stockholders of the Company, other than a merger, scheme of arrangement or consolidation which
would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%)
of the total voting power represented by the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or
  

(d)    the date of the consummation of the sale, transfer or disposition by the Company of
all or substantially all of the Company’s assets;
  
 Notwithstanding the
foregoing, a transaction will not constitute a Change in Control if: (i) its sole purpose is to change the domicile of the Company’s incorporation; or (ii) its sole purpose is to create a holding company that will be owned in substantially the
same proportions by the persons who held the Company’s securities immediately before such transaction;

		
	 “Commencement Date”
	  	means the date of this Agreement and the Appointees period of continuous employment commenced on December 1st, 2004;
		
	 “Confidential Business Information”
	  	 means all and any Corporate Information, Marketing Information, Technical Information and other information (whether or not reduced
to writing and whether or not recorded in documentary form or on computer disk or tape or any other medium) in the possession of the Company or any Associated Company whether owned by the Company or any Associated Company or by any third party
(including, without limitation, the suppliers, Customers, consultants, licensees or service providers of the Company or any Associated Company) and to which the Company or any Associated Company attaches an equivalent level of confidentiality or in
respect of which it owes an obligation of confidentiality to any third party:
  
 (a)    which the Appointee will acquire at any time during his employment under this Agreement but which does not form part of the Appointee’s own stock-in-trade provided that the
Appointee’s own stock-

  
 5 

 Execution Copy 

 

			
		  	 in-trade will not include any matters which, under the terms hereof, the Appointee recognises are the property of
the Company and/or of any of its Associated Companies;
  
 (b)    which is not known or readily ascertainable to persons not connected with the Company or any Associated Company either at all or without a significant expenditure of labour,
skill or money; and
  

(c)    which provide the Company or any Associated Company with a competitive advantage and
that could not easily be determined or learned by a third party;

		
	 “Corporate Information”
	  	means all and any information (whether or not reduced to writing and whether or not recorded in documentary form or on computer disk or tape or any other medium) relating to the
business affairs of the Company or any Associated Company including, without limitation, business methods, corporate plans, management systems, finances, administration of Customer accounts, personnel, protocols, quality assurance, maturing new
business opportunities or research and development projects;
		
	 “Customer”
	  	means any person, firm or company to whom the Company or any Associated Company will at the Termination Date be actively seeking to sell or supply any Restricted Product or
provide any Restricted Service or to whom the Company or any Associated Company will at any time during the period of two (2) years before the Termination Date have supplied any Restricted Product or provided any Restricted Service; as well as any
person, firm or company with whom the Company or any Associated Company has established or is actively seeking to establish a strategic alliance;
		
	 “Good Reason”
	  	 means without the Appointee’s express written consent, any of the following “Good Reason
Conditions”:
  

(e)    the Company commits a material breach of the Agreement which is not remedied by the
Company within fifteen (15) days of receiving written notice from the Appointee that specifically sets forth the factual basis of the Appointee’s belief that a material breach has occurred;

 
 (f)     a
diminution of the Appointee’s salary of

  
 6 

 Execution Copy 

 

			
		  	 more than 10% (provided that for purposes of clause 15.2 of the Agreement only, a diminution of the
Appointee’s salary of less than 10% other than in connection with an across-the-board salary reduction affecting all senior executives of the Company will give rise to a Good Reason Condition);

 
 (g)    a material change
in the geographic location at which the Appointee provides services to the Company (provided that for this purpose, in no event will a relocation of such provision of services to a new location less than fifty (50) miles from the current location of
the provision of services give rise to a Good Reason Condition);
  
 (h)    a material diminution in the Appointee’s responsibilities, authority or duties; or
  

(i)     a successor to the Company fails to assume the Agreement in writing upon
becoming a successor or assignee of the Company. With respect to each of the Good Reason Conditions described above, the Appointee may not establish “Good Reason” unless he has provided written notice of the existence of such condition to
the Company within 30 days of the event constituting such Good Reason, the Company fails to reasonably cure such condition within the 15 day period immediately following receipt of such notice and the Appointee terminates his employment within sixty
(60) days after providing written notice of the existence of a Good Reason Condition or end of the cure period, whichever is later;

		
	 “Incapacity”
	  	means any illness (including mental disorder), injury or other like cause incapacitating the Appointee from attending to his duties;
		
	 “Inventions”
	  	means all ideas, inventions, discoveries, improvements, designs, formulae, processes, production methods and technological innovations;
		
	 “Marketing Information”
	  	means all and any information (whether or not reduced to writing and whether or not recorded in documentary form or on computer disk or tape or any other medium) relating to the
marketing or sales of any past, present or future product or

  
 7 

 Execution Copy 

 

			
		
		  	service of the Company or any Associated Company including (without limitation) sales targets and statistics, market share and pricing statistics, marketing surveys and plans,
market research reports, sales techniques, price lists, discount structures, advertising and promotional material, the names, addresses, telephone numbers, contact names and identities of Customers of and suppliers and potential suppliers to the
Company or any Associated Company, the characteristics and preferences of any Customer or any such supplier including, without limitation, the nature of their business operations, their requirements for any product or service sold to or purchased by
the Company or any Associated Company and all confidential aspects of their business relationship with the Company or any Associated Company;
		
	 “Restricted Area”
	  	means any country in the world where, on the Termination Date, the Company or any Associated Company develops, sells or supplies its products or services;
		
	 “Restricted Products”
	  	means any products of the same or similar kind to those which will be developed, supplied, marketed or sold by the Company or any Associated Company during the twelve (12) months
immediately preceding the Termination Date;
		
	 “Restricted Services”
	  	means all and any services of the same or similar kind to those which will be provided by the Company or any Associated Company during the twelve (12) months immediately
preceding the Termination Date;
		
	 “Technical Information”
	  	means all and any trade secrets, secret formulae, processes, inventions, designs, know-how, discoveries, technical specifications and other technical information (whether or not
reduced to writing and whether or not recorded in documentary form or on computer disk or tape or any other medium) relating to the creation, production or supply of any past, present or future product or service of the Company or any Associated
Company; and
		
	 “Termination Date”
	  	means the date on which this Agreement is terminated irrespective of the cause or manner.

  

	1.2	Words importing one gender will include all other genders and words importing the singular will include the plural and vice versa. 

  
 8 

 Execution Copy 

 

	1.3	Any reference to a statutory provision will be deemed to include a reference to any statutory modification or re-enactment thereof. 

 

	1.4	The headings in this Agreement are for convenience only and will not affect its construction or interpretation. 

 

	2	Employment 

 The Company
will employ the Appointee from and including the Commencement Date and the Appointee will serve the Company as Chief Technology Officer, reporting to the Chief Executive Officer upon and subject to the terms and conditions set out in this Agreement.

  

	3	Term 

 The employment will
continue until terminated by the Company giving to the Appointee his statutory minimum notice entitlement or terminated by the Appointee giving to the Company 6 months’ notice in writing. This clause is without prejudice to the terms of clause
15 below. 
  

	4	Duties 

  

	4.1	The Appointee will at all times during the continuance of this Agreement: 

  

	 	(a)	devote the whole of his time, attention and ability to the duties of his appointment; 

 

	 	(b)	faithfully, efficiently, competently and diligently perform such duties and exercise such powers consistent with them as are from time to time assigned to or vested in
him by the Board in his capacity as director or in connection with the business of the Company; 

  

	 	(c)	obey all lawful and reasonable directions of the Board; 

  

	 	(d)	use his best endeavours to promote and extend the business of the Company and its Associated Companies and to protect and further the reputation and the interests of
the Company and its Associated Companies; 

  

	 	(e)	keep the Board promptly and fully informed (in writing if so requested) of his conduct of the business or affairs of the Company and its Associated Companies and
provide such explanations as the Board may require; 

  

	 	(f)	not at any time make any untrue or misleading statement relating to the Company or any Associated Company. 

 

	4.2	The Appointee will (without further remuneration) if and for so long as the Company requires during the continuance of this Agreement: 

 

	 	(a)	carry out duties on behalf of any Associated Company; 

  

	 	(b)	act as an officer of any Associated Company or hold any other appointment or office as nominee or representative of the Company or any Associated Company;

  

	 	(c)	carry out such duties and the duties attendant on any such appointment as if they were duties to be performed by him on behalf of the Company. 

  
 9 

 Execution Copy 

 

	4.3	Notwithstanding the foregoing or any other provision of this Agreement, the Company will not be under any obligation to vest in or assign to the Appointee any powers or
duties and may at any time and for any period either require the Appointee to perform: 

  

	 	(a)	a part only of his normal duties and no other; 

  

	 	(b)	such duties as it may reasonably require and no others; 

  

	 	(c)	no duties whatsoever; 

 or
suspend or exclude the Appointee from the performance of his duties, provided that throughout any such period the Appointee’s remuneration and contractual benefits will not cease to be payable by reason thereof. 

 

	5	Place of Work 

  

	5.1	The Appointee will carry out his duties at such place of business of the Company or of any Associated Company as the Company may from time to time require.

  

	5.2	The Appointee will visit and travel to such places, whether in or outside Ireland, by such means and on such occasions as the Company may from time to time require for
the purpose only of performing his duties hereunder. 

  

	6	Remuneration 

  

	6.1	The Company will pay to the Appointee during the continuance of his appointment hereunder a salary at the rate of €170,000 per annum (or at such higher rate
as may from time to time be agreed pursuant to sub-clause 6.2). Such salary will include any sums receivable as director’s fees or other remuneration from any Associated Company or from any other company or unincorporated body in which he holds
office as nominee or representative of the Company or any Associated Company. The said salary, which will be deemed to accrue from day to day, will be payable by bank credit transfer in equal monthly instalments in arrears on or before the last
working day of each calendar month. 

  

	6.2	The salary payable in accordance with sub-clause 6.1 will be reviewed by the Board on the anniversary of the Commencement Date in each year and the salary may be
increased by the Board with effect from such date by such amount (if any) as it thinks fit. 

  

	6.3	The Appointee may participate in an annual bonus of up to €75,000 based on Fleetmatics Group Limited achieving the targets set out in the business plan as approved
by the Board from time to time. 

  

	6.4	The Company will make a contribution to the Appointee’s pension plan in an amount equivalent to 5% of annual salary. 

 

	6.5	The Company will also provide VHI cover for the Appointee. 

  

	7	Expenses 

 The Company
will reimburse to the Appointee all reasonable travelling, subsistence, entertainment and other out-of-pocket expenses wholly, exclusively and necessarily incurred by him in or about the proper performance of his duties under this Agreement provided
that the Appointee complies with such guidelines or regulations issued by the Company from time to time in this respect and provides reasonable evidence of the expenditure in respect of which he claims reimbursement. 

  
 10 

 Execution Copy 

 

	8	Holidays 

  

	8.1	Subject to sub-clause 8.2, in addition to public holidays the Appointee is entitled to 20 working days paid holiday in each calendar year to be taken at such time or
times as may be approved by the Board. The Appointee will not without the prior consent of the Board carry forward more than seven (7) days of any unused holiday entitlement to a subsequent year. 

 

	8.2	For the year during which his appointment commences or terminates, the Appointee is entitled to 1 2/3 working days holiday for each complete calendar month of his
employment by the Company during that year. 

  

	8.3	On termination of his appointment for whatever reason, the Appointee will either be entitled to pay in lieu of holiday entitlement accrued under sub-clause 8.2 or be
required to repay to the Company any salary received for holiday taken in excess of such entitlement. 

  

	9	Incapacity 

  

	9.1	If the Appointee will be prevented by Incapacity from properly performing his duties hereunder he will report this fact forthwith to the Chief Executive Officer and if
the Appointee is so prevented for seven or more consecutive days he will provide a medical practitioner’s statement on the eighth day and weekly thereafter so that the whole period of the Incapacity is certified by such statements. Immediately
following his return to work after a period of absence due to Incapacity the Appointee will complete a Self-Certification Form available from the Chief Executive Officer detailing the reason for his absence. 

 

	9.2	If the Appointee will be absent from his duties hereunder due to Incapacity duly certified in accordance with sub-clause 9.1, he will be paid his full remuneration
hereunder (which will include salary whether in lieu of notice or otherwise) for up to sixty (60) working days’ absence in any period of twelve (12) consecutive months and thereafter such remuneration, if any, as the Board will
determine from time to time provided that such remuneration will be inclusive of any social welfare sickness benefit to which the Appointee is entitled under the provisions of the Social Welfare Acts and any such sickness or other benefits
recoverable by the Appointee (whether or not recovered) may be deducted therefrom. 

  

	9.3	If the Incapacity will be or appear to be occasioned by actionable negligence of a third party in respect of which damages are or may be recoverable the Appointee will
immediately notify the Board of the fact and of any claim, compromise, settlement or judgment made or awarded in connection with it and will give to the Board all particulars the Board may reasonably require and will (if so required by the Board)
refund to the Company such part of any damages recovered relating to loss of earnings for the period of the Incapacity as the Board may reasonably determine, provided that: 

 

	 	(a)	the amount to be refunded will not exceed either the amount of the damages or compensation recovered by the Appointee less any costs borne by him in connection with
such recovery or the total remuneration paid to the Appointee by way of salary in respect of the period of the Incapacity; 

  

	 	(b)	in the event of partial recovery by the Appointee under any such claim, compensation, settlement or judgment, recovery in respect of loss of remuneration will be deemed
to be made after recovery in respect of any other head of claim. 

  

	9.4	 At any time during the continuance of this Agreement, the Appointee will at the request and expense of the Company permit himself to be examined by a
registered medical practitioner to be selected by the Company and will authorise such medical practitioner to disclose to and 

  
 11 

 Execution Copy 

 

	 	
discuss with the Company’s medical adviser the results of such examination and any matters which arise from it in order that the Company’s medical adviser may notify the Company of any
matters which, in the medical adviser’s opinion, might hinder or prevent the Appointee (if during a period of Incapacity) from returning to work for any period or (in other circumstances) from properly performing any duties of his appointment
at any time. 

  

	10	Confidential Business Information 

  

	10.1	The Appointee hereby acknowledges that: 

  

	 	(a)	the protections provided by this Agreement are necessary to safeguard the Confidential Business Information and other business interests of the Company and each of the
Associated Companies and that the Company is willing to employ the Appointee only if he agrees to accept and abide by the undertakings and obligations set forth herein; 

 

	 	(b)	during the course of his employment with the Company or any of its Associated Companies he will have access to the Confidential Business Information, the Company and
each of the Associated Companies has created and gathered such information at great cost and over time and that such information is not generally known and cannot easily be obtained from publicly available sources. 

Accordingly, the Appointee agrees to use his best efforts, both during and after his employment by the Company or any of its Associated
Companies, to hold all of the Confidential Business Information in a fiduciary capacity for the benefit of the Company and each Associated Company and to safeguard such Confidential Business Information and that he will not, directly or indirectly,
use, disclose or communicate any of such information except as may be necessary in the good faith performance of his duties to the Company or any of its Associated Companies. 

 

	10.2	The rights set forth in this Agreement are in addition to any rights the Company or any Associated Company may have under common law or applicable statutes relating to
the protection of trade secrets and other confidential information. 

  

	11	Records 

 The Appointee
hereby acknowledges and agrees that any records, files, memoranda, computer programs, reports, price lists, fee schedules, Customer or service provider lists, marketing plans, programs or forecasts and other written or printed documents or tangible
items of any nature or materials or other data stored on computer disks or any other medium (“Documents”) received, created or used by him during the course of his employment with the Company or any of its Associated Companies are
and will remain the sole and exclusive property of the Company and the Associated Companies and he will not without the prior authority of the Company remove from the premises of the Company or copy the contents thereof or allow others to remove or
copy the contents thereof and he agrees to return all Documents (including all copies) to the Company forthwith upon request and, in any event, promptly upon the termination of his employment howsoever arising. The Appointee agrees that, during or
after his employment, he will not, under any circumstances, without the specific prior authorisation in writing of an officer of the Company, disclose or communicate in any manner any of the Documents or any information contained in any of the
Documents to any third party or use or permit or authorise the use or publication of any of the Documents for any purpose other than the advancement of the interests of the Company and the Associated Companies. 

  
 12 

 Execution Copy 

 

	12	Restrictions during Employment 

  

	12.1	The Appointee covenants that during the continuance of this Agreement he will not: 

 

	 	(a)	engage, whether as director, officer, employee, consultant, partner, principal, agent or otherwise, or be concerned or interested, whether directly or indirectly, in
any other business of a similar nature to or competitive with any business carried on by the Company or any Associated Company or which is a supplier or customer of the Company or any Associated Company in relation to its goods or services, provided
that nothing in this clause 12 will preclude the Appointee from holding or being otherwise interested in any shares or other securities of any company which are for the time being quoted on any stock exchange so long as the interest of the Appointee
in such shares or other securities does not extend to more than three (3) per cent of the total amount of such shares or securities; 

  

	 	(b)	directly or indirectly receive or obtain in respect of any goods or services sold or purchased or other business transacted (whether or not by him) by or on behalf of
the Company or any Associated Company any discount, rebate, commission or other inducement (whether in cash or in kind) and if he or any firm or company in which he is interested, whether as director, officer, employee, consultant, partner,
principal or agent, (if a company) as the holder (directly or indirectly) of any shares, debentures or other securities extending to more than three (3) per cent of the total amount of such shares, debentures or securities, will obtain any such
discount, rebate, commission or inducement, he will immediately account to the Company for the amount received by him (or a due proportion of the amount received by such firm or company having regard to the extent of his interest therein); and

  

	 	(c)	at any time during the continuance of this Agreement speak in public, take part in any radio or television programme or write any letter or article for publication on
any matter connected with or relating to the business of the Company or any Associated Company without first obtaining the approval of the Board. 

  

	12.2	Subject to the express terms of this Agreement, while an employee of the Company, the Appointee will devote his full-time efforts to the Company’s business and
will not engage in any other business activity that conflicts with his duties to the Company. The Appointee will advise the Chief Executive Officer or his or her nominee at such time as any activity of either the Company or another business presents
to the Appointee with a conflict of interest or the appearance of a conflict of interest as an employee of the Company. The Appointee will take whatever action as requested by the Company to resolve any conflict or appearance of conflict which the
Company finds to exist. 

  

	13	Inventions 

  

	13.1	If at any time in the course of his employment under this Agreement the Appointee (whether alone or with any other person or persons and whether or not during working
hours) conceives or makes any Inventions, whether or not patentable, which either directly or indirectly: 

  

	 	(a)	relate to the business of the Company or any Associated Company; 

  

	 	(b)	result from tasks assigned to the Appointee by the Company; 

  
 13 

 Execution Copy 

 

	 	(c)	are based on or derived from the Appointee’s knowledge of the actual or planned business activities of the Company or any Associated Company; or

  

	 	(d)	are aided by the use of materials, facilities or information belonging to the Company or any Associated Company; the Appointee will promptly disclose to the Company
full details, including, without limitation, drawings and models, of such Inventions. 

  

	13.2	The Appointee agrees to assign (and to bind his heirs, executors and administrators, to assign) to the Company or to such of the Associated Companies as the Company may
designate all Inventions covered by this clause 13. 

  

	13.3	Without further compensation but at the Company’s expense, the Appointee agrees to give all testimony and execute all patent applications, rights of priority,
assignments and other documents and in general do all lawful things requested of him by the Company or any Associated Company to enable any of them to obtain, maintain and enforce its or their rights in and to the Inventions.

  

	13.4	The Appointee recognises that any Invention which is conceived or made by him at any time from the date hereof up to and including the date which is one year after the
Termination Date, howsoever arising, is likely to have been conceived in significant part in the course of his employment with the Company or an Associated Company. Accordingly, the Appointee agrees that any such Invention will be presumed to have
been conceived in the course of his employment with the Company or any of its Associated Companies unless and until he establishes the contrary by clear and convincing evidence. 

 

	13.5	Decisions as to the patenting and exploitation of any Invention will be at the sole discretion of the Company. 

 

	13.6	The Appointee irrevocably appoints the Company to be his attorney in his name and on his behalf to execute documents, to use the Appointee’s name and to do all
things which may be necessary or desirable for the Company to obtain for itself or its nominee the full benefit of the provisions of clause 13 above and a certificate in writing signed by any director or the secretary of the Company that any
instrument or act falls within the authority hereby conferred will be conclusive evidence that such is the case so far as any third party is concerned. 

  

	14	Copyright Works and Designs 

  

	14.1	The Appointee will promptly disclose to the Company all copyright works or designs originated, conceived, written or made by him alone or with others from and including
the Commencement Date (except only those works originated, conceived, written or made by him wholly outside his normal working hours which are wholly unconnected with his employment) and will hold them in trust for the Company until such rights will
be fully and absolutely vested in the Company. 

  

	14.2	The Appointee hereby assigns to the Company by way of future assignment all copyright, design rights and other proprietary rights (if any) for the full terms thereof
throughout the world in respect of all copyright works and designs originated, conceived, written or made by the Appointee (except only those works or designs originated, conceived, written or made by the Appointee wholly outside his normal working
hours which are wholly unconnected with his employment) during the continuance of this Agreement. 

  

	14.3	The Appointee hereby irrevocably and unconditionally waives in favour of the Company any and all moral rights conferred on him by law for any work in which copyright or
design right is vested in the Company whether pursuant to sub-clause 14.2 above or otherwise. 

  
 14 

 Execution Copy 

 

	14.4	The Appointee will, at the request and expense of the Company, do all things necessary or desirable to substantiate the rights of the Company under sub-clauses 14.2 and
14.3 above and will not knowingly do anything to imperil the validity of such rights. 

  

	15	Termination / Severance 

Except as otherwise provided below, if Appointee’s employment with the Company terminates for any reason, then (i) all vesting
will terminate immediately with respect to the Appointee’s outstanding equity based awards not yet vested, (ii) all payments of compensation by the Company to the Appointee hereunder will terminate immediately (except as to salary earned
up to and including the last day of employment and the annual bonus amounts already earned and declared but not yet paid for the prior calendar year, if any). In addition, the following terms will apply depending on the circumstances of the
Appointee’s termination: 
  

	15.1	Termination without Cause or Resignation for Good Reason apart from a Change of Control If prior to or absent a Change of Control: 

 

	 	(a)	the Company terminates the Appointee’s employment without Cause; or 

  

	 	(b)	the Appointee resigns from employment for Good Reason, 

 then, subject to clauses 15.7 to 15.9, the Appointee will be entitled to the following less his statutory notice pay: 
  

	 	(i)	receive continuing payments as severance pay at a rate equivalent to his monthly salary, as then in effect, for six (6) months; and 

 

	 	(ii)	if the Appointee was participating in the Company’s group health plan immediately prior to the Termination Date, then subject to the Appointee electing and
remaining eligible for participation under the plan in accordance with its terms and all applicable laws, the Company will pay the employer portion of the premiums for such plan(s) to the same extent as if the Appointee had remained employed by the
Company during the six (6) month salary continuation period. 

  

	15.2	Termination without Cause or Resignation for Good Reason within six (6) months after a Change of Control 

If within six (6) months after a Change of Control: 
  

	 	(a)	the Company terminates the Appointee’s employment with the Company without Cause; or 

 

	 	(b)	the Appointee resigns from employment for Good Reason, 

 then, subject to clauses 15.7 to 15.9, the Appointee will be entitled to the following less his statutory notice pay: 
  

	 	(i)	receive continuing payments as severance pay at a rate equal to his monthly salary, as then in effect, for twelve (12) months; 

 

	 	(ii)	 if the Appointee was participating in the Company’s group health plan immediately prior to the Termination Date, then subject to the Appointee
electing and remaining eligible for participation under the plan in accordance with its terms and all applicable laws, the Company will pay the employer 

  
 15 

 Execution Copy 

 

	 	
portion of the premiums for such plan(s) to the same extent as if the Appointee had remained employed by the Company during the twelve (12) month salary continuation period; and

  

	 	(iii)	subject to the provisions of the Company’s stock option plan, 100% of any outstanding stock options not yet vested will become immediately vested upon the
Termination Date or resignation. 

  

	15.3	Termination for Cause or Resignation without Good Reason 

 If the Appointee’s employment with the Company is terminated voluntarily by the Appointee (except upon resignation for Good Reason), or for Cause by the Company, then: 

 

	 	(a)	all vesting will terminate effective on the Termination Date with respect to the Appointee’s outstanding equity awards not yet vested; 

 

	 	(b)	all payments of compensation by the Company to the Appointee hereunder will terminate immediately (except as to salary earned up to and including the Termination Date
and annual bonus amounts already earned and declared but not yet paid for the prior calendar year, if any); and 

  

	 	(c)	the Appointee will be eligible for severance benefits in accordance with the Company’s established policies then in effect, if any, for severance for employees
terminated by the Company without Cause or who resign without Good Reason. 

  

	15.4	Termination upon Death or Disability 

 If the Appointee’s employment terminates due to the Appointee’s death or disability, then: 
  

	 	(a)	all payments of compensation by the Company to the Appointee hereunder will terminate immediately (except as to salary up to and including the Termination Date and
annual bonus amounts already earned and declared but not yet paid for the prior calendar year, if any); 

  

	 	(b)	the Appointee will only be eligible for severance benefits in accordance with the Company’s established policies, if any, as then in effect; and

  

	 	(c)	in addition to the number of shares that have would have vested as of the Termination Date pursuant to the schedule set forth in applicable Equity Documents, a number
of shares will vest equal to the number of shares which would have otherwise vested if the Appointee had remained employed with the Company up to and including six (6) months of the Termination Date. 

For the purposes of this clause 15.4, the Appointee’s employment may be terminated as a result of disability if the Appointee is
disabled and unable to perform the essential functions of the Appointee’s then existing position or positions under this Agreement with or without reasonable accommodation for a period of 120 days (which need not be consecutive) in any 12-month
period. If any question will arise as to whether during any period the Appointee is disabled so as to be unable to perform the essential functions of the Appointee’s then existing position or positions with or without reasonable accommodation,
the Appointee may, and at the request of the Company will, submit to the Company a certification in reasonable detail by a medical practitioner selected by the Company to whom the Appointee or the Appointee’s guardian has no reasonable
objection as to whether the Appointee is so disabled or how long such disability is expected to continue, and such certification will for the purposes of this Agreement be conclusive of the issue. Notwithstanding the foregoing, such certification
will 

  
 16 

 Execution Copy 

 

 
not be used to circumvent or reduce the time period of 120 days in any 12-month period. The Appointee will co-operate with any reasonable request of the medical practitioner in connection with
such certification. If such question will arise and the Appointee will fail to submit such certification within fifteen (15) days following a formal request by the Company, the Company’s determination of such issue will be binding on the
Appointee. Nothing in this clause 15.4 will be construed to waive the Appointee’s rights, if any, under existing applicable laws. 
  

	15.5	Upon termination of this Agreement howsoever arising the Appointee will forthwith upon the request of the Company, resign without claim for compensation from all
offices held in the Company or any Associated Company and should he fail to do so the Company is hereby irrevocably authorised to appoint some person in his name and on his behalf to sign and do any documents or thing necessary or requisite to give
effect thereto. 

  

	15.6	It is agreed by the Company and the Appointee that the termination of this Agreement in accordance with this clause 15 will for all purposes be treated as if it were
for a substantial and sufficient reason of a kind justifying the dismissal of the Appointee and that the giving of notice in those circumstances will be treated as fair and reasonable. 

 

	15.7	The receipt of any severance payments, benefits or equity acceleration pursuant to this clause 15 (the “Severance Amount”) will be subject to the
Appointee signing a release agreement in favour of the Company and related persons and entities in a form reasonably required by the Company (the “Release”) within 60 days following the Termination Date. No Severance Amount will be
paid or provided unless the Release becomes fully effective. The Severance Amount will be paid in substantially equal instalments in accordance with the Company’s payroll practice over six (6) months, commencing within 60 days after the
Termination Date; provided, however, that if the 60 day period begins in one calendar year and ends in a second calendar year, the Severance Amount will begin to be paid in the second calendar year. 

 

	15.8	Receipt of any Severance Amount pursuant to this clause 15 will be subject to the Appointee not violating the post termination provisions in this Agreement. In the
event the Appointee breaches any such post termination provisions, the Company will, in addition to all other legal and equitable remedies, have the right to terminate or suspend the Severance Amount without affecting the Appointee’s Release or
the Appointee’s obligations under the Release. 

  

	15.9	The Appointee will not be required to mitigate the Severance Amount contemplated by the Agreement, nor will any earnings that the Appointee may receive from any other
source reduce any such Severance Amount. 

  

	16	Post-Termination Provisions 

  

	16.1	The Appointee acknowledges that: 

  

	 	(a)	the Company and each Associated Company has a compelling business interest in preventing the use or disclosure of the Confidential Business Information in the event
that, after the termination of his employment with the Company or any of its Associated Companies, he goes to work for or becomes affiliated with a competitor of the Company or of any of the Associated Companies or otherwise engages in business
activities that are competitive with the Businesses; and 

  

	 	(b)	 the Company and the Associated Companies are engaged in a highly competitive business and that, by virtue of the position in which he is employed by
the Company or any of its Associated Companies, his engaging in or working 

  
 17 

 Execution Copy 

 

	 	
for or with any business which is directly or indirectly competitive with the Businesses will cause the Company and the Associated Companies great and irreparable harm. 

 

	16.2	Accordingly, the Appointee covenants and agrees that he will not, directly or indirectly: 

 

	 	(a)	within the Restricted Area for a period of twelve (12) months after the Termination Date, without the prior written consent of the Board, in competition with the
Company, engage, whether as director, officer, employee, consultant, partner, principal, agent or otherwise, or participate or be concerned or interested in any business or activity of a similar nature to or, wholly or partly, in competition with
any of the Businesses or engage in preparations for any activity prohibited by this sub-clause 16.2(a); 

  

	 	(b)	within the Restricted Area for a period of twelve (12) months after the Termination Date, without the prior written consent of the Board, in competition with the
Company, engage whether as director officer, employee, consultant, partner, principal, agent or otherwise, or participate or be concerned or interested in any business or activity (other than those to which sub-clause 16.2(a) above refers) which
requires or might reasonably be thought by the Company to require him to publish, disclose or communicate in any manner or make use of any of the Confidential Business Information in order properly to discharge his duties to or to further his
interest in such business. 

  

	16.3	Notwithstanding the provisions of sub-clause 16.2 should the Appointee desire to work for a competitor of the Company or of any Associated Company, or otherwise to
compete with the Businesses or any of them following the Termination Date and prior to the expiry of the twelve (12) month period referred to in sub-clause 16.2, he agrees to give the Company not less than thirty (30) days advance notice,
in writing, of his desire to engage in such competitive activity. In that event, the Company may agree, in its sole and unreviewable discretion, to waive its rights under sub-clause 16.2 above. The factors that the Company may consider in deciding
whether to waive its rights under sub-clause 16.2 include, but are not limited to, the following: 

  

	 	(a)	the Appointee’s position and responsibilities with the Company or any of its Associated Companies; 

 

	 	(b)	the reason for the termination of the Appointee’s employment with the Company or any of its Associated Companies; 

 

	 	(c)	the length of time the Appointee was employed by the Company or any of its Associated Companies; 

 

	 	(d)	the nature of the Appointee’s new employment; and 

  

	 	(e)	the people or organisations affiliated with the planned competition. 

  

	16.4	The Appointee acknowledges that, by virtue of his employment with the Company or any of its Associated Companies, he will gain knowledge of the identity,
characteristics and preferences of the Customers, among other Confidential Business Information, and that he would more likely than not have to draw on such Confidential Business Information if he were to solicit or service the Customers on behalf
of a competing business enterprise. Accordingly, the Appointee covenants and agrees that he will not directly or indirectly: 

  

	 	(a)	for a period of twelve (12) months after the Termination Date in any capacity whatsoever seek any business, orders or custom for any Restricted Products or
Restricted Services from any Customer with whom he had a material business relationship and/or in respect of whom he had Confidential Information; 

  
 18 

 Execution Copy 

 

	 	(b)	for a period of twelve (12) months after the Termination Date in any capacity whatsoever accept any business, orders or custom for any Restricted Products or
Restricted Services from any Customer with whom he had a material business relationship and/or in respect of whom he had Confidential Information. 

  

	16.5	The Appointee also agrees that he will not directly or indirectly: 

  

	 	(a)	for a period of twelve (12) months after the Termination Date, in any capacity whatsoever, hire or solicit or entice away or seek to hire or entice away from the
Company or any Associated Company any person who is and was at the Termination Date an employee of the Company with whom the Appointee had material contact or dealings during the course of his employment hereunder or any employee who had material
contact with customers or suppliers of the Company during the course of his employment with the Company or any Associated Company, or any person who was a director or manager responsible for sales, or a director or manager responsible for marketing
or products or technology and with whom the Appointee had contact or dealings during the course of his employment hereunder; 

  

	 	(b)	at any time after the Termination Date seek to disrupt or otherwise interfere with or prejudice the continuance of the supply of goods and/or services to the Company or
any Associated Company or the terms of such supply; 

  

	 	(c)	at any time after the Termination Date represent himself or permit himself to be held out by any person, firm or company as being in any way connected with or
interested in the Company or any Associated Company save to the extent of any shareholding in the Company or any Associated Company held by him for so long only as he holds the same; 

 

	 	(d)	at any time after the Termination Date disclose or communicate in any manner to any person, firm or company or make use of any of the Confidential Business Information
(other than information which the Appointee is required to disclose by law). 

  

	16.6	In the event that the Appointee violates any of the provisions of clauses 10, 11, 12, 13, 14 or 15 and the Company initiates any proceeding against him in connection
therewith, the time period of the restrictive covenants set forth above will be tolled until the final adjudication (by a court or arbitrator of competent jurisdiction) of any such proceedings. 

 

	16.7	If and when the Appointee departs from the Company, the Appointee may be required to attend an exit interview and sign an “Employee Exit Acknowledgement” to
reaffirm his acceptance and acknowledgement of the obligations set forth in this Agreement. For twelve (12) months following termination of the Appointee’s employment, the Appointee will notify the Company of any change in his address and
of each subsequent employment or business activity, including the name and address of his employer or other post-Company employment plans and the nature of his activities. 

 

	17	Health, Safety and Security 

 The Company will take all reasonable action to ensure the health and safety of its staff. As an employee, the Appointee will also have certain responsibilities and obligations to safeguard its

  
 19 

 Execution Copy 

 

 
health, safety and wellbeing and that of its colleagues, visitors and contractors. The Appointee should familiarise itself with the Company’s health and safety policy and safety statement.
Please note that breaching these obligations could result in disciplinary action. 
  

	18	Tax Withholding 

 All
payments made pursuant to this Agreement will be subject to the withholding of all applicable taxes, social insurance or national insurance or other similar contributions, amounts due under the PAYE or PRSI systems or any other deductions required
by law. 
  

	19	Acknowledgement of the Appointee 

 The Appointee hereby acknowledges that he considers the restrictions and agreements set out in clauses 10, 11, 12, 13, 14 and 16 to be fair, reasonable and necessary for the protection of the legitimate
commercial interests of the Company and each of the Associated Companies, that the Company and the Associated Companies will suffer irreparable harm in the event of any actual or threatened breach by the Appointee of any of the provisions of clauses
10, 11, 12, 13, 14 or 16 and the payment of money alone would not cover the harm the breach would cause. It is hereby agreed that if any of the provisions of clauses 10, 11, 12, 13, 14 or 16 are held to be void or invalid but would not have been so
held if part of the wording were deleted, the periods thereof reduced or area covered thereby reduced in scope or the extent thereof reduced or modified, then such provisions will apply with such modifications as may be necessary to make the same
valid and enforceable. 
  

	20	Notices 

  

	20.1	Any notice required or permitted to be given under this Agreement will be given in writing delivered personally or sent by first class post pre-paid recorded delivery
(air mail if overseas) to the party due to receive such notice at, in the case of the Company, its registered office address from time to time and, in the case of the Appointee, his address as set out in this Agreement (or such address as he may
have notified to the Company in accordance with this sub-clause 20.1). 

  

	20.2	Any notice delivered personally will be deemed to be received when delivered to the address provided in sub-clause 20.1 and any notice sent by pre-paid recorded
delivery post will be deemed (in the absence of evidence of earlier receipt) to be received two days after posting (six days if sent by air mail) and in proving the time of despatch it will be sufficient to show that the envelope containing such
notice was properly addressed, stamped and posted. 

  

	21	Disclosures 

 Any
disclosure required to be made by the Appointee to the Company will be made in writing delivered personally or sent by first class post pre-paid recorded delivery to the Company’s registered office address from time to time. 

 

	22	Statutory Particulars 

The further particulars of terms of employment not contained in the body of this Agreement which are required to be given to the Appointee
by the Terms of Employment (Information) Act, 1994 are set out hereto. 
  

	23	Equal Opportunity and Sexual Harassment 

 The Company is committed to the principle of equal opportunity in the workplace and is committed to ensuring that the workplace should be free from sexual harassment. Any breach of this policy will be
considered misconduct and may result in disciplinary proceedings or your employment being terminated. The Appointee also agrees to participate in and co-operate with the Company in any investigation of allegation of sexual harassment. 

  
 20 

 Execution Copy 

 

	24	Miscellaneous 

  

	24.1	This Agreement contains the entire and only agreement and will govern the relationship between the Company and the Appointee from the Commencement Date in substitution
for all previous agreements and arrangements whether written, oral or implied between the Company and the Appointee relating to the services of the Appointee all of which agreements and arrangements will be deemed to have been terminated by mutual
consent with effect from the Commencement Date. The Appointee and the Company acknowledge that in entering into this Agreement neither has relied on any representation or undertaking by the other whether oral or in writing save as expressly
incorporated herein. 

  

	24.2	On termination of employment however arising the Appointee shall not be entitled to any compensation for the loss of any rights or benefits under any share option,
long-term incentive plan or other profit sharing scheme operated by the Company or any Associated Company in which he may participate. For the avoidance of any doubt, no such right or benefit shall form part of the Appointees terms and conditions of
employment hereunder. 

  

	24.3	The expiration or termination of this Agreement howsoever arising will not operate to affect such of the provisions of this Agreement as are expressed to operate or
have effect after then and will be without prejudice to any accrued rights or remedies of the parties. 

  

	24.4	In the event of the termination of this Agreement by the Company for whatever reason the Appointee hereby agrees that any redundancy payment to which he may become
entitled under the Minimum Notice and Terms of Employment Act 1973 including any statutory modification or re-enactment thereof at the time being in force will be applied in reduction of any other sums for which the Company may be liable to the
Appointee by reason of such termination. 

  

	24.5	None of the terms of this Agreement may be amended, modified or altered except by a written agreement signed by the Appointee and the Company. 

 

	24.6	Neither this Agreement nor any rights or obligations under this Agreement will be assignable by the Appointee. This Agreement and the rights and obligations of the
Company hereunder will be assignable by the Company. 

  

	24.7	The finding of a court of competent jurisdiction that any provision of this Agreement is illegal, invalid or unenforceable will not render any other provision of this
Agreement illegal, invalid or unenforceable. Such court will have the authority to modify or replace the invalid or unenforceable term or provision with a valid and enforceable term or provision which most accurately represents the parties’
intention with respect to the invalid or unenforceable term or provision. 

  

	24.8	This Agreement will be binding upon and inure to the benefit of the heirs, executors, personal representatives, administrators or other legal representatives of the
Appointee. This Agreement will be binding upon and inure to the benefit of the Company and its successors, assigns and legal representatives. 

  

	24.9	The rights granted to the Company hereunder extend to each of the Associated Companies and the undertakings given by the Appointee hereunder are given for the benefit
of the Company and each of the Associated Companies. Accordingly, the Appointee hereby acknowledges and agrees that the rights of the Company and the undertakings given by him hereunder will be enforceable either by the Company and/or by all or any
of the Associated Companies. 

  
 21 

 Execution Copy 

 

	24.10	The failure of either party at any time to enforce any of the terms, covenants or conditions of this Agreement or to exercise any right hereunder will not constitute a
waiver of the same or affect that party’s right thereafter to enforce the same. 

  

	24.11	No term, covenant or condition of this Agreement or any breach thereof will be deemed waived, except with the prior written consent of the party against whom the waiver
is claimed and any waiver of any such term, covenant, condition or breach will not be deemed to be a waiver of any preceding or succeeding breach, whether of the same or any other term, covenant, condition or breach. 

 

	24.12	The Appointee hereby confirms and acknowledges that prior to signing this Agreement he has had the full opportunity to consult with legal and other professional
advisers of his choice as to the meaning of this Agreement and the rights and obligations which he has under this Agreement and he has a full understanding of the same. 

 

	24.13	Each of the parties hereby acknowledges that he or it and his or its legal advisers has reviewed and revised or had an opportunity to review and revise this Agreement
and the normal rules of construction to the effect that any ambiguities are to be resolved against the drafting party will not be employed in the interpretation of this Agreement. 

 

	24.14	This Agreement may be executed in any number of counterparts, and thus consist of several documents in this form, each of which will be deemed to be an original and
which together will constitute the same Agreement. This Agreement will become effective and dated on the latest date on which a signature is stated to have been made hereto. 

 

	24.15	The rights and remedies granted hereunder are in addition to, and not in lieu of, any rights or remedies which the Company and/or any Associated Company may have in law
or in equity. 

  

	24.16	The validity, construction and performance of this Agreement and all non-contractual obligations arising from or connected with it will be governed by the laws of the
Republic of Ireland and all disputes, claims or proceedings between the parties in relation thereto will be subject to the non-exclusive jurisdiction of the Irish Courts to which the parties irrevocably submit. 

In witness whereof this Agreement has been entered into the day and year first above written. 

  
 22 

 Execution Copy 

 

 Statutory Particulars 
 Information relating to employment agreement required to be given by employer to employee pursuant to the Terms of Employment (Information) Act, 1994 

 

			
	Full Name of Employer:	  	See Service Agreement
		
	Full Name of Employee:	  	See Service Agreement
		
	Address of Employer in the State:	  	See Service Agreement
		
	Place of Work or Statement re various places of work:	  	See Service Agreement
		
	Title/Nature of Job/Work:	  	See Service Agreement
		
	Date of commencement of employment:	  	See Service Agreement
		
	If temporary employment, expected duration thereof; If fixed term, date on which contract expires:	  	Not applicable
		
	Rate, or method of calculation of remuneration:	  	See Service Agreement
		
	Intervals of remuneration:	  	See Service Agreement
		
	Hours of work (including 0/T):	  	See Service Agreement
		
	Paid leave terms:	  	See Service Agreement
		
	Incapacity terms:	  	See Service Agreement
		
	Pension/pension scheme term:	  	See Service Agreement
		
	Notice required from employee to terminate, or method for determining period of notice:	  	See Service Agreement
		
	Notice required from employer to terminate, or method for determining such periods of notice:	  	See Service Agreement
		
	Collective Agreements affecting terms and conditions of employment:	  	None
		
	 Employment outside the State (Strike out if not applicable:

 
 •    Period of
employment outside the State
  

•    Currency of remuneration

 
 •    Any benefits
in cash or kind for the employee attendent on employment outside the State
  
 •    Terms and conditions governing repatriation
	  	

  
 23 

 Execution Copy 

 

 Dated: 
 Signed:                                
             

             Employer 
 Copy for retention during employment and for one year thereafter. 

  
 24 

 Execution Copy 

 

			
	 Signed by
 for and on behalf
of
	  	
		
	Fleetmatics Irl Limited	  	
	in the presence of:	  	

  

	
	
	  

	Witness
	
	  

	Address
	
	  

	
	  

	Occupation

  

			
	Signed by Peter Mitchell	  	
		
	in the presence of:	  	

  

	
	  

	Witness
	
	  

	Address
	
	  

	
	  

	Occupation

  
 25Employment Agreement, Dennis Abrahams

 Exhibit 10.11 
 EMPLOYMENT AGREEMENT 
 This Employment Agreement (the
“Agreement”) is entered into as of July 30, 2010 (the “Effective Date”) by and between FleetMatics Group Limited (the “Company”), FleetMatics USA, Inc., 49 Walnut Park, Wellesley Hills, MA
02481 (“U.S. Subsidiary”) and Dennis Abrahams of 6260 North Huntington Drive, Solon, OH 44139 (“Executive”). The parties hereby agree as follows 

1. Description: 
 The Executive shall initially serve as the President of the SageQuest business. The Executive initially report to, take direction from and assume such duties and responsibilities consistent with his
position as are assigned to him by the principal executive officer of the U.S. Subsidiary or such other person designated by the Board of Directors of the Company (the “Board”) from time to time. The Executive shall devote his full
working time and efforts to the business and affairs of the Company provided however, nothing in this Agreement shall be construed to prevent the Executive from engaging in any of the following activities provided such activities do not
interfere with the performance of Executive’s duties to the Company: (i) passively investing Executive’s assets, (ii) performing work for charitable or other nonprofit institutions, or (iii) serving on for profit boards of
directors subject to Section 1(b) and with the express written approval of the principal executive officer of the U.S. Subsidiary. 
 (a) Obligations. During Executive’s employment he will not engage in any other employment, occupations or consulting activity for any direct or indirect remuneration for any activity that
would create a conflict of interest or the appearance of a conflict of interest between Executive and U.S. Subsidiary or the Company, without the prior approval of the Board. 
 (b) Employment. U.S. Subsidiary will employ Executive on the terms and conditions set forth herein. Executive will receive his cash compensation and benefits from U.S. Subsidiary and U.S.
Subsidiary will maintain and distribute employment-related records. The payment and performance of U.S. Subsidiary’s obligations under this Agreement is a joint and several obligations of U.S. Subsidiary and the Company. 

2. At-Will Employment. Subject to the severance provisions set forth in Section 7 below, the parties agree that
Executive’s employment with U.S. Subsidiary will be “at-will” employment and may be terminated at any time with or without cause or notice subject to the terms of this Agreement. Executive understands and agrees that neither his job
performance nor promotions, commendations, bonuses or the like from the Company or U.S. Subsidiary give rise to or in any way serve as the basis for modification, amendment, or extension, by implication or otherwise, of his at-will employment status
with the U.S. Subsidiary. 

 3. Compensation. 

(a) Base Salary. Executive’s initial base salary shall be paid at the rate of $290,000 (two hundred and ninety thousand
dollars) per year, payable bi-weekly in accordance with U.S. Subsidiary’s normal payroll practices and be subject to the usual, required deductions and withholdings. Executive’s base salary will be subject to review based upon the U.S.
Subsidiary’s normal performance review practices but may be decreased only if the percentage decrease applies to all other senior executives of the U.S. Subsidiary. The annual base salary in effect at any given time is referred to herein as
“Base Salary.” 
 (b) Annual Bonus. Executive will be eligible to earn a bonus at an annual target of
35% (thirty five percent) of Base Salary (pro rated for 2010), less applicable withholding taxes, based on the achievement of performance objectives to be determined by the Board. The Executive’s target, performance objectives and the
achievement of those objectives shall be determined in the sole discretion of the Board or the Compensation Committee of the Board. The annual bonus in effect at any given time is referred to herein as the “Annual Bonus”. Except as
otherwise provided herein, to earn any part of the Annual Bonus, the Executive must be employed by the U.S. Subsidiary on December 31 of the applicable bonus year. Any Annual Bonus shall be paid between January 1 and March 15 of the
year following the year in which such Annual Bonus is earned. 
 (c) Stock Options. Within sixty (60) days of the
Closing Date as defined in that certain Agreement and Plan of Merger, dated June 30, 2010 by and among the Company, Archon Acquisition Corporation, SageQuest, Inc. (“SageQuest”) and Tom Parkinson (the “Merger
Agreement”), the Company shall grant Executive stock options pursuant to the terms of the Company’s stock option program. The number of shares subject to such options and the vesting schedule of such options, whether time based or
performance based, shall be determined by the Board. 
 4. Employee Benefits. During his employment, Executive will be
entitled to participate in the employee benefit plans currently and hereafter maintained by the U.S. Subsidiary of general applicability to other senior executives of the U.S. Subsidiary residing in the United States of America. The U.S. Subsidiary
will provide one hundred percent (100%) of the cost of Health, Dental and Vision benefit. The Company and U.S. Subsidiary reserves the right to cancel or change the benefit plans and programs it offers to its employees at any time. 

5. Vacation. Executive will be entitled to paid vacation of four (4) weeks per year, accrued on a pro rata basis in
accordance with U.S. Subsidiary’s vacation policy. 
 6. Expenses. U.S. Subsidiary will reimburse Executive for
reasonable travel, entertainment or other expenses incurred by Executive in the furtherance of or in connection with the performance of Executive’s duties hereunder, in accordance with U.S. Subsidiary’s expense reimbursement policy as in
effect from time to time. 
 7. Termination/Severance. Except as otherwise provided below, if Executive’s employment
with the U.S. Subsidiary terminates for any reason, then (i) all vesting will terminate immediately with respect to Executive’s outstanding stock options not yet vested, (ii) all payments of compensation by the Company or U.S.
Subsidiary to Executive hereunder will terminate immediately (except as to Base Salary earned through the last day of employment 

  
 2 

 
and Annual Bonus amounts already earned but not yet paid for the prior calendar year, if any). In addition, the following terms shall apply depending on the circumstances of the Executive’s
termination: 
 (a) Termination Without Cause Apart from a Change of Control. If prior to or absent a Change of Control
or after six (6) months following a Change of Control, the U.S. Subsidiary terminates Executive’s employment without Cause, then, subject to Section 8, Executive will be entitled to: (A) receive continuing payments of severance
pay at a rate equal to his Base Salary rate, as then in effect, for six (6) months, unless such termination occurs within twelve months of the Effective Date, in which case the severance pay shall be for a twelve (12) month period; and
(B) Company-paid coverage for Executive and Executive’s eligible dependents under U.S. Subsidiary’s Benefit Plans for six (6) months following such termination, unless such termination occurs within twelve months of the Effective
Date, in which case the coverage shall be paid for a twelve (12) month period. 
 (b) Termination Without Cause within
Six Months after a Change of Control or Resignation for Good Reason. If (i) within six (6) months after a Change of Control the U.S. Subsidiary terminates Executive’s employment with the U.S. Subsidiary without Cause, or
(ii) at any time during the Executive’s employment, Executive resigns from employment for Good Reason, then, subject to Section 8, Executive will be entitled to: (A) receive continuing payments of severance pay at a rate equal to
his Base Salary rate, as then in effect, for six (6) months, unless such termination or resignation occurs within twelve months of the Effective Date, in which case the severance shall be paid for a twelve (12) month period; and
(B) Company-paid coverage for Executive and Executive’s eligible dependents under U.S. Subsidiary’s Benefit Plans for six (6) months following such termination or resignation, unless such termination or resignation occurs within
twelve months of the Effective Date, in which case the coverage shall be paid for a twelve (12) month period. 
 (c)
Termination for Cause: Resignation without Good Reason. If Executive’s employment with the U.S. Subsidiary terminates voluntarily by Executive (except upon resignation for Good Reason), or for Cause by the Company, then (i) all
vesting will terminate immediately with respect to Executive’s outstanding stock options not yet vested, (ii) all payments of compensation by the Company or U.S. Subsidiary to Executive hereunder will terminate immediately (except as to
Base Salary earned through the last day of employment and Annual Bonus amounts already earned but not yet paid for the prior calendar year, if any), and (iii) Executive will be eligible for severance benefits in accordance with the U.S.
Subsidiary’s established policies, if any, as then in effect. 
 (d) Termination Upon Death or Disability. If
Executive’s employment terminates due to Executive’s death or disability, then (i) all payments of compensation by the Company or U.S. Subsidiary to Executive hereunder will terminate immediately (except as to salary through the last
day of employment and Annual Bonus amounts already earned, if any), (ii) Executive will only be eligible for severance benefits in accordance with the Company’s established policies, if any, as then in effect, and (iii) in addition to
the number of shares of stock options that have vested as of the date of such termination pursuant to the schedule set forth in Section 3(c), a number of shares of stock options will vest equal to the number of shares of stock options that
would have otherwise vested if Executive had remained employed with the U.S. 

  
 3 

 
Subsidiary through the anniversary of the Effective Date immediately following the date of such termination. For the purposes of this Agreement, Executive’s employment may be terminated as a
result of disability if Executive is disabled and unable to perform the essential functions of the Executive’s then existing position or positions under this Agreement with or without reasonable accommodation for a period of 120 days (which
need not be consecutive) in any 12-month period. If any question shall arise as to whether during any period Executive is disabled so as to be unable to perform the essential functions of Executive’s then existing position or positions with or
without reasonable accommodation, the Executive may, and at the request of the Company shall, submit to the Company a certification in reasonable detail by a physician selected by the Company to whom the Executive or the Executive’s guardian
has no reasonable objection as to whether the Executive is so disabled or how long such disability is expected to continue, and such certification shall for the purposes of this Agreement be conclusive of the issue. Notwithstanding the foregoing,
such certification shall not be used to circumvent or reduce the time period of 120 days in any 12 month period. The Executive shall cooperate with any reasonable request of the physician in connection with such certification. If such question shall
arise and the Executive shall fail to submit such certification, the Company’s determination of such issue shall be binding on the Executive. Nothing in this Section 7(d) shall be construed to waive the Executive’s rights, if any,
under existing law including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. §2601 et seq. and the Americans with Disabilities Act, 42 U.S.C. §12101 et seq. 

8. Receipt of Severance: No Duty to Mitigate. 
 (a) Separation Agreement/Commencement of Severance Pay. The receipt of any severance pursuant to Section 7 will be subject to Executive signing and not revoking a release agreement in the form
substantially similar to the form attached hereto as Exhibit A, provided that edits may be made to reflect the circumstances of the ending of Executive’s employment, the applicable provisions of this Agreement and changes in the law. No
severance will be paid or provided unless the release agreement becomes fully effective. If the conditions are met, the severance shall begin on the U.S. Subsidiary’s first regular payroll date that occurs 35 days after the last day of
Executive’s employment. Solely for purposes of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), each installment payment is considered a separate payment. 

(b) Noncompete/Nonsolicitation. The receipt of any severance pursuant to Section 7 will be subject to Executive not violating
the Non-Competition Agreement referenced in Section 10 of this Agreement and attached hereto as Exhibit B, the terms of which are hereby incorporated by reference. In the event Executive breaches the Non-Competition Agreement the Company shall
have the right to terminate or suspend all continuing payments and benefits to which Executive may otherwise be entitled pursuant to Section 7 without affecting the Executive’s release or obligations under the release agreement.

 (c) No Duty to Mitigate. Executive will not be required to mitigate the amount of any severance payment contemplated
by this Agreement, nor will any earnings that Executive may receive from any other source reduce any such severance payment. 

  
 4 

 9. Definitions. 

(a) Benefit Plans. For purposes of this Agreement, “Benefit Plans” means plans, policies or arrangements that the
Company and/or U.S. Subsidiary sponsors (or participates in) and that immediately prior to Executive’s termination of employment provide Executive and/or Executive’s eligible dependents with medical, dental, and/or vision benefits. Benefit
Plans do not include any other type of benefit (including, but not by way of limitation, disability, life insurance or retirement benefits). A requirement that the Company provide Executive and Executive’s eligible dependents with coverage
under the Benefit Plans will be satisfied if the coverage is not materially less favorable than that provided to senior executives of the Company or U.S. Subsidiary that reside in the United States of America at any applicable time during the period
Executive is entitled to receive severance pursuant to Section 7(a) or (b). At the Executive’s option, the Company may satisfy any requirement that the Company provide coverage under any Benefit Plan by (i) reimbursing
Executive’s premiums under Title X of the Consolidated Budget Reconciliation Act of 1985, as amended (“COBRA”) after Executive has properly elected continuation coverage under COBRA (in which case Executive will be solely
responsible for electing such coverage for his eligible dependents), or (ii) providing coverage under a separate plan or plans providing coverage that is not materially less favorable or by paying Executive a lump sum payment which is, on an
after-tax basis, sufficient to provide Executive and Executive’s eligible dependents with substantially equivalent coverage under a third party plan that is reasonably available to Executive and Executive’s eligible dependents. If the
Company elects to make the lump sum payment provided for under Section 9(a)(ii) to satisfy the Company’s obligations under Section 7(a) or (b), such payment shall be made upon the release agreement required by Section 8(a)
becoming effective (or, if later, the date of Executive’s without Cause termination or, if applicable, Good Reason resignation). 
 (b) Cause. For purposes of this Agreement, “Cause” is defined as (i) a proven act of dishonesty made by Executive in connection with Executive’s responsibilities as an
employee that results in proven material injury to the Company, (ii) Executive’s conviction of, or plea of nolo contendere to, a felony or any crime involving fraud, embezzlement or any other act of moral turpitude,
(iii) Executive’s proven gross misconduct that results in proven material injury to the Company, (iv) Executive’s proven unauthorized use or disclosure of any proprietary information or trade secrets of the Company or any other
party to whom Executive owes an obligation of nondisclosure as a result of Executive’s relationship with the Company; (v) Executive’s proven willful breach of any material obligations under any material written agreement or covenant
with the Company; or (vi) Executive’s continued failure to substantially perform his material employment duties after Executive has received a written demand of performance from the Company which specifically sets forth the factual basis
for the Company’s belief that Executive has not substantially performed his material duties and has failed to cure such non-performance to the Company’s satisfaction within fifteen (15) business days after receiving such notice.

 (c) Change of Control. For purposes of this Agreement, “Change of Control” of the Company is defined
as: 
 (i) any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange
Act of 1934, as amended) who is not a shareholder of the Company as of the date of this Agreement or an affiliate thereof is or becomes the “beneficial owner” (as defined in Rule 13d-3 under said Act), directly or indirectly, of securities
of the Company representing 50% or more of the total voting power represented by the Company’s then outstanding voting securities; or 

  
 5 

 (ii) a change in the composition of the Board occurring within a two-year
period, as a result of which less than a majority of the directors are Incumbent Directors. “Incumbent Directors” will mean directors who either (A) are directors of the Company as of the date hereof, or (B) are elected,
or nominated for election, to the Board with the affirmative votes of at least a majority of the remaining Incumbent Directors at the time of such election or nomination (but will not include an individual whose election or nomination is in
connection with an actual or threatened proxy contest relating to the election of directors to the Company); or 

(iii) the date of the consummation of a merger, scheme of arrangement or consolidation of the Company with any other
corporation that has been approved by the stockholders of the Company, other than a merger, scheme of arrangement or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to
represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving
entity outstanding immediately after such merger or consolidation; or 
 (iv) the date of the consummation of the
sale or disposition by the Company of all or substantially all the Company’s assets. 
 Notwithstanding the foregoing, a transaction will
not constitute a Change in Control if: (i) its sole purpose is to change the state of the Company’s incorporation; or (ii) its sole purpose is to create a holding company that will be owned in substantially the same proportions by the
persons who held the Company’s securities immediately before such transaction. 
 (d) Good Reason. For the purposes
of this Agreement, “Good Reason” means without Executive’s express written consent, any of the following “Good Reason Conditions”: (i) the Company and/or the U.S. Subsidiary commits a material breach of
this Agreement which is not remedied by the Company and/or the U.S. Subsidiary within fifteen (15) days of receiving written notice from Executive that specifically sets forth the factual basis for Executive’s belief that a material breach
has occurred; (ii) a material diminution in the Executive’s responsibilities, authority or duties provided that changes in job title, reporting structure and/or job responsibilities in connection with the post-merger integration of the
Sagequest business and the Company and/or the U.S. Subsidiary shall not constitute a Good Reason Condition provided the Executive continues to retain at least a substantially similar level of authority at the integrated entity; (iii) a
diminution in the Executive’s Base Salary except for an across-the-board salary reduction affecting all senior executives of the U.S. Subsidiary; (iv) the relocation of Executive to a facility or a location more than fifty (50) miles
from Executive’s location on the Effective Date hereof; (v) the Company fails to timely grant Executive the stock options referenced in Section 3(c) or the amount or vesting or other material economic terms of the stock options are
unacceptable to Executive as determined by the Executive in his sole 

  
 6 

 
discretion; (vi) within the one year period that immediately follows the Effective Date of this Agreement, the Executive is required to report directly to someone other than the principal
executive officer of the U.S. Subsidiary; or (vii) a successor to the Company fails to assume this Agreement in writing upon becoming a successor or assignee of the Company. With respect to each of the Good Reason Conditions described above,
Executive may not establish “Good Reason” unless he has provided written notice of the existence of such condition to the Company within 30 days of the event constituting such Good Reason, the Company fails to reasonably cure such
condition within the 15-day period immediately following receipt of such notice and the Executive terminates his employment within sixty (60) days after providing written notice of the existence of a Good Reason Condition or end of the cure
period, whichever is later. 
 10. Confidential Information/Restrictive Covenants. Executive agrees to enter into the
Company’s standard Non-Competition, Confidentiality and Assignment Agreement (the “Non-Competition Agreement”) upon commencing employment hereunder, attached hereto as Exhibit A and the terms of which are hereby incorporated by
reference as material terms of this Agreement. 
 11. Assignment. This Agreement will be binding upon and inure to the
benefit any successor of the Company and any successor of a U.S. subsidiary. Any such successor of the Company and any U.S. subsidiary will be deemed substituted for the Company or U.S. subsidiary, respectively, under the terms of this Agreement for
all purposes. For this purpose “successor” means any person, firm, corporation or other business entity which at any time, whether by purchase, merger, scheme of arrangement or otherwise, directly or indirectly acquires all or
substantially all of the assets or business of either or both the Company or U.S. subsidiary. None of the rights of Executive to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred except by will or the
laws of descent and distribution. Any other attempted assignment, transfer, conveyance or other disposition of Executive’s right to compensation or other benefits will be null and void. This Agreement shall be binding upon and inure to the
benefit of Executive and, with respect to Section 7(d), Executive’s legal representatives or heirs. 
 12.
Notices. All notices, requests, demands and other communications called for hereunder will be in writing and will be deemed given (i) on the date of delivery if delivered personally, (ii) two (2) business days after the
business day of deposit with Federal Express or a similar courier for next business day (or, internationally, second business day) delivery, or (iii) seven (7) days after being mailed by registered or certified mail, return receipt
requested, prepaid and addressed to the parties or their successors at the following addresses, or at such other addresses as the parties may later designate in writing: 
 If to the Company: 
 FleetMatics USA, Inc. 

49 Walnut Park 

Wellesley Hills 

MA 02481  

Attn: Chief Executive Officer, Jim Travers 

  
 7 

 With a copy to: 
 Goodwin Procter LLP 
 Exchange Place 

53 State Street 

Boston, MA 02109 

Fax: (617) 523-1231 
 Attention: Mark T. Bettencourt, Esq. 
 Email: mbettencourt@goodwinprocter.com

 If to Executive: 
 6260 North Huntington Drive 
 Solon, OH 44139 

13. Severability. In the event that any provision hereof becomes or is declared by a court of competent jurisdiction to be
illegal, unenforceable or void, this Agreement will continue in full force and effect without said provision. 
 14.
Arbitration. To ensure the rapid and economical resolution of disputes that may arise in connection with Executive’s employment with the Company or U.S. Subsidiary, Executive and the Company agree that any and all disputes, claims, or
causes of action, in law or equity, arising from or relating to the enforcement, breach, performance, or interpretation of this Agreement, Executive’s employment, or the termination of Executive’s employment, shall be resolved, to the
fullest extent permitted by law, by final, binding and confidential arbitration in Boston, Massachusetts, conducted by the Judicial Arbitration and Mediation Services, Inc. (“JAMS”) or its successor, under the then applicable rules
of JAMS. Executive and the Company acknowledge that by agreeing to this arbitration procedure, each party waives the right to resolve any such dispute through a trial by jury or judge or administrative proceeding. The arbitrator shall: (a) have
the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision including the arbitrator’s essential findings and
conclusions and a statement of the award. The arbitrator shall be authorized to award any or all remedies that Executive or the Company would be entitled to seek in a court of law. Nothing in this Agreement is intended to prevent either the
Executive or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. 

Notwithstanding the foregoing, Executive and the Company each have the right to petition the court for injunctive relief and seek damages relating to any
issue or dispute arising under the Non-Competition Agreement. 
 15. Integration. This Agreement, and the Non-Competition
Agreement represents the entire agreement and understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral, including, without limitation, that certain Employment
Agreement dated as of October 15, 2009, by and between SageQuest, Inc. and Executive, provided however, the stock options referenced in Section 3(c) 

  
 8 

 
shall be governed by the applicable stock option plans and agreements. This Agreement may be modified only by agreement of the parties by a written instrument executed by the parties that is
designated as an amendment to this Agreement. 
 16. Waiver of Breach. The waiver of a breach of any term or provision of
this Agreement, which must be in writing, will not operate as or be construed to be a waiver of any other previous or subsequent breach of this Agreement. 
 17. Headings. All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement. 

18. Tax Withholding. All payments made pursuant to this Agreement will be subject to withholding of applicable taxes. 

19. Governing Law/Consent to Jurisdiction. This Agreement will be governed by the laws of the Commonwealth of Massachusetts (with
the exception of its conflict of laws provisions). The parties hereby expressly consent to the personal jurisdiction of the state and federal courts located in the Commonwealth of Massachusetts for any action or proceeding arising from or relating
to this Agreement and/or relating to any arbitration in which the parties are participants. The parties hereby agree that the state and federal courts in Commonwealth of Massachusetts shall have the exclusive jurisdiction to consider any matters
related to this Agreement, including without limitation any claim for violation of this Agreement. With respect to any such court action, the Executive (i) submits to the jurisdiction of such courts, (ii) consents to service of process,
and (iii) waives any other requirement (whether imposed by statute, rule of court or otherwise) with respect to personal jurisdiction or venue. 
 20. Acknowledgment. Executive acknowledges that he has had the opportunity to discuss this matter with and obtain advice from his private attorney, has had sufficient time to, and has carefully
read and fully understands all the provisions of this Agreement, and is knowingly and voluntarily entering into this Agreement. 

21. Counterparts. This Agreement may be executed in counterparts, and each counterpart will have the same force and effect as an
original and will constitute an effective, binding agreement on the part of each of the undersigned. 
 22. Attorney’s
Fees. In the event of a dispute between the parties under this Agreement, the prevailing party shall be entitled to recover its costs and attorney’s fees from the non-prevailing party, including those incurred at trial, arbitration, and on
appeal. 
 23. 409A. Anything in this Agreement to the contrary notwithstanding, if at the time of the Executive’s
separation from service within the meaning of Section 409A of the Code, the Company determines that the Executive is a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any
payment or benefit that the Executive becomes entitled to under this Agreement on account of the Executive’s separation from service would be considered deferred compensation subject to the 20 percent additional tax imposed pursuant to
Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment shall not be payable and such benefit shall not be provided until the date that is the earlier of (A) six months and one
day after the 

  
 9 

 
Executive’s separation from service, or (B) the Executive’s death. If any such delayed cash payment is otherwise payable on an installment basis, the first payment shall include a
catch-up payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision, and the balance of the installments shall be payable in accordance with their original schedule. All in-kind
benefits provided and expenses eligible for reimbursement under this Agreement shall be provided by the Company or incurred by the Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as
administratively practicable, but in no event shall any reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses
incurred in one taxable year shall not affect the in-kind benefits to be provided or the expenses eligible for reimbursement in any other taxable year. Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for
another benefit. To the extent that any payment or benefit described in this Agreement constitutes “non-qualified deferred compensation” under Section 409A of the Code, and to the extent that such payment or benefit is payable upon
the Executive’s termination of employment, then such payments or benefits shall be payable only upon the Executive’s “separation from service.” The determination of whether and when a separation from service has occurred shall be
made in accordance with the presumptions set forth in Treasury Regulation Section 1.409A-1(h). The parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any provision of
this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in such a manner so that all payments hereunder comply with Section 409A of the Code. The parties agree that this Agreement may be
amended, as reasonably requested by either party, and as may be necessary to fully comply with Section 409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional
cost to either party. The Company makes no representation or warranty and shall have no liability to the Executive or any other person if any provisions of this Agreement are determined to constitute deferred compensation subject to
Section 409A of the Code but do not satisfy an exemption from, or the conditions of, such Section. 

  
 10 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	The Company
		
	By:	 	  

		 	Name:
		 	Title:
	
	The Executive
		
	By:	 	  

	Dennis Abrahams
	
	SageQuest, Inc.
		
	By:	 	  

		 	Name:
		 	Title:

  
 11 

 EXHIBIT A 
 RELEASE AGREEMENT 
 This Release (“Release Agreement”) is made
between David Lowman (“Executive”) and FleetMatics USA, Inc., a subsidiary of FleetMatics Group Limited (collectively the “Company”) 
 WHEREAS, the Parties entered into an Employment Agreement dated June     , 2010; 
 WHEREAS, among other things, the Employment Agreement includes a Noncompetition Agreement which is a material term of the Employment Agreement and survives the termination of Executive’s
employment;  
 WHEREAS, pursuant to the Employment Agreement, the Company agreed to provide Executive with
certain severance payments (the “Severance”) in the event of a termination by the Company without Cause or a resignation by the Executive with Good Reason provided that, among other things, the Executive enters into a release agreement in
a form substantially similar to this Release Agreement; 
 WHEREAS, in exchange for, among other things, Executive’s
agreement to the terms of and compliance with this Release Agreement, the Company shall provide Executive with the Severance as provided in the applicable provision of Section 7 of the Employment Agreement; and 

WHEREAS, the non-contingent accrued payments set forth in Section 2 and the Severance referenced in Section 3 are the
exclusive payments and benefits to Executive in connection with the ending of Executive’s employment. By entering into this Release Agreement, Executive acknowledges and agrees that he is not entitled to any other severance pay, benefits
including without limitation pursuant to any severance plan, or program or arrangement, provided however, nothing in this Release Agreement shall affect Executive’s rights with respect to previously granted stock options which are governed by
the terms and conditions of the applicable stock option plans and agreements. 
 NOW, THEREFORE, for good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties hereby agree as follows: 
 1.
Resignation from Officer Positions and Directorships. The Executive hereby resigns as of the last day of his employment (the “Separation Date”) as an officer of the Company, as well as from any other officer or director
positions he holds with the Company or any entities affiliated with the Company. The Executive agrees to sign any other documents that the Company may reasonable request in order to effectuate such resignation(s). 

2. Non-Contingent Accrued Payments. The Executive acknowledges that the Company has paid Executive’s salary through
the Separation Date plus for his accrued but unused vacation and any Annual Bonus earned under the Employment Agreement but not yet paid. The Company shall reimburse Executive for any outstanding, reasonable business

 
expenses that Executive has incurred on the Company’s behalf through the Separation Date, provided the Company receives appropriate documentation pursuant to the Company’s business
expense reimbursement policy on or before [date]. 
 3. Severance. For purposes of the Employment
Agreement, the Executive’s employment shall be treated [as having been terminated by the Company without Cause] or [as ending as a result of Executive resigning for Good Reason]. Accordingly, in exchange for, among other things, his signing,
not revoking and complying with the terms of this Release Agreement and the Restrictive Covenants, the Company agrees to provide Executive with the following Severance as set forth in the Employment Agreement: 

(a) [describe applicable severance terms]. 
 4. General Release. Executive irrevocably and unconditionally releases and forever discharges the Company, all of its affiliated and related entities, its and their respective predecessors,
successors and assigns, its and their respective Executive benefit plans and the fiduciaries of such plans, and the current and former officers, directors, stockholders, Executives, attorneys, accountants, and agents of each of the foregoing in
their official and personal capacities (collectively referred to as the “Releasees”) generally from all claims, demands, debts, damages and liabilities of every name and nature, known or unknown (“Claims”) that, as of the date
when Executive signs this Release Agreement, he has, ever had, now claims to have or ever claimed to have had against any or all of the Releasees. This release includes, without implication of limitation, the complete waiver and release of all
Claims of or arising in connection with or for: the Employment Agreement including Claims for breach of express or implied contract; wrongful termination of employment whether in contract or tort; intentional, reckless, or negligent infliction of
emotional distress; breach of any express or implied covenant of employment, including the covenant of good faith and fair dealing; interference with contractual or advantageous relations, whether prospective or existing; deceit or
misrepresentation; discrimination or retaliation under state, federal, or municipal law, including, without implication of limitation, Title VII of the Civil Rights Act of 1964, 42 U.S.C. § 2000e et seq., as amended, the Americans with
Disabilities Act, 42 U.S.C. § 12101 et seq., the Age Discrimination in Employment Act, 29 U.S.C. § 621 et seq.; Massachusetts Gen. L. ch 151B; the Ohio Fair Employment Practices Act, defamation or damage to reputation; reinstatement;
punitive or emotional distress damages; wages, severance pay, vacation pay, back or front pay or other forms of compensation; and attorney’s fees and costs. Executive understands that this general release of Claims extends to any and all Claims
related to Executiveâs employment by the Company and the termination of his employment and all claims in his capacity as a Company stockholder. Executive understands that this general release does not extend to any rights or claims that may
arise out of acts or events that occur after the date on which Executive signs this Agreement. Executive represents that he has not assigned to any third party and has not filed with any agency or court any Claim released by this Agreement
provided however, this general release shall not affect the Executive’s rights (i) to the non-contingent accrued payments set forth in Section 2, (ii) arising under the Merger Agreement (as defined in the Employment
Agreement) or (iii) to indemnification arising from the Company’s bylaws or any other agreement or insurance policy. 

  
 2 

 5. Continuing Obligations and Nondisparagement. Executive hereby reaffirms his
continuing obligations with respect to noncompetition, nonsolicitation and nondisclosure arising from the Noncompetition Agreement shall remain in full force and effect, regardless of whether the Executive enters into this Release Agreement.
Executive further agrees not to make any disparaging statements concerning the Company or any of its affiliates or current or former officers, directors, shareholders, employees or agents. Executive further agrees not to take any actions or conduct
himself in any way that would reasonably be expected to affect adversely the reputation or goodwill of the Company or any of its affiliates or any of its current or former officers, directors, shareholders, employees or agents (collectively, along
with the continuing obligations under the Noncompetition Agreement, and the Return of Property provisions in Section 6, the “Restrictive Covenants”). The nondisparagement obligations set forth herein shall not affect Executive’s
obligation to testify truthfully in any legal proceeding. 
 6. Return of Property. Executive commits to returning
to the Company all Company property, including, without limitation, computer equipment, software, keys and access cards, credit cards, files and any documents (including computerized data and any copies made of any computerized data or software)
containing information concerning the Company, its business or its business relationships. After returning all such property, Executive commits to deleting and finally purging any duplicates of files or documents that may contain Company or customer
information from any computer or other device that remains Executive’s property after the Separation Date. 
 7.
Restrictive Covenants; Termination of Payments; Injunctive Relief. Executive acknowledges that his right to the Severance is conditional on his compliance with the Restrictive Covenants. In the event that Executive fails to comply with
any of the Restrictive Covenants, in addition to any other legal or equitable remedies it may have for such breach, the Company shall have the right to terminate the Severance set forth in Section 3 of this Release Agreement provided
however, in the event the breach of the Restrictive Covenants is in the form of the Executive making disparaging statements or failing to return the Company’s property, the breach must be material to justify a termination of the
Executive’s Severance. Any such termination in the event of a breach by the Executive shall not affect the Executive’s ongoing obligations and shall be in addition to and not in lieu of the Company’s rights to other legal and
equitable remedies that the Company may have. Further, Executive agrees that it would be difficult to measure any harm caused to the Company that might result from any breach by Executive of any of the Restrictive Covenants and that, in any event,
money damages would be an inadequate remedy for any such breach. Accordingly, Executive agrees that if he breaches, or proposes to breach, any portion of the Restrictive Covenants the Company shall be entitled, in addition to all other remedies it
may have, to an injunction or other appropriate equitable relief to restrain any such breach, without showing or proving any actual damage to the Company and without the necessity of posting a bond. 

8. Advice of Counsel. This Release Agreement is a legally binding document and Executiveâs signature will commit
Executive to its terms. Executive acknowledges that he has been advised to discuss all aspects of this Release Agreement with his attorney, that he has carefully read and fully understands all of the provisions of this Release Agreement and that
Executive is voluntarily entering into this Release Agreement. 

  
 3 

 9. Time for Consideration; Effective Date. Executive acknowledges that he has
been provided with the opportunity to consider this Agreement for twenty-one (21) days before signing it. To accept this Agreement, Executive must return a signed original of this Agreement so that it is received by [insert], on or
before the expiration of this twenty-one (21) day period. If Executive signs this Agreement within less than twenty-one (21) days of the date of its delivery to him, Executive acknowledges by signing this Agreement that such decision was
entirely voluntary and that he had the opportunity to consider this Agreement for the entire twenty-one (21) day period. Executive and the Company agree that any changes or modifications to this Agreement shall not restart the twenty-one
(21) day period. For a period of seven (7) days from the day of the execution of this Agreement, Executive shall retain the right to revoke this Agreement by written notice that must be received by [insert] before the end of such
revocation period. This Agreement shall become effective on the business day immediately following the expiration of the revocation period (the “Effective Date”), provided that Executive does not revoke this Agreement during the revocation
period. 
 10. Enforceability. Executive acknowledges that, if any portion or provision of this Release Agreement
or the Restrictive Covenants shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby,
and each portion and provision shall be valid and enforceable to the fullest extent permitted by law. 
 11. Entire
Agreement. This Release Agreement along with the Restrictive Covenants incorporated herein constitute the entire agreement between Executive and the Company concerning Executive’s relationship with the Company, and supersedes and
replaces any and all prior agreements and understandings between the Parties concerning the Executive’s relationship with the Company including, without limitation, the Employment Agreement, provided however, the stock option plan and
agreements applicable to Executive’s equity grants shall remain in full force and effect. 
 12. Waiver. No
waiver of any provision of this Release Agreement, including the Restrictive Covenants, shall be effective unless made in writing and signed by the waiving party. The failure of either Party to require the performance of any term or obligation of
this Release Agreement, or the waiver by either Party of any breach of this Release Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach. 

13. Taxes. The Company shall undertake to make deductions, withholdings and tax reports with respect to payments and
benefits under this Release Agreement and in connection with other compensation matters to the extent that it reasonably and in good faith determines that it is required to make such deductions, withholdings and tax reports. Payments under this
Release Agreement shall be in amounts net of any such deductions or withholdings. Nothing in this Release Agreement shall be construed to require the Company to make any payments to compensate Executive for any adverse tax effect associated with any
payments or benefits made to Executive in connection with Executiveâs employment with the Company. 
 14. Governing
Law; Interpretation. This Release Agreement shall be interpreted and enforced under the laws of the Commonwealth of Massachusetts without regard to conflict 

  
 4 

 
of law principles. In the event of any dispute, this Release Agreement is intended by the parties to be construed as a whole, to be interpreted in accordance with its fair meaning, and not to be
construed strictly for or against either Party or the “drafter” of all or any portion of this Release Agreement. 

15. Counterparts. This Release Agreement may be executed in any number of counterparts, each of which when so executed and
delivered shall be taken to be an original, but all of which together shall constitute one and the same document. Facsimile and pdf signatures shall be deemed to be of equal force and effect as originals. 

I HAVE READ THIS AGREEMENT THOROUGHLY, UNDERSTAND ITS TERMS AND HAVE SIGNED IT KNOWINGLY AND VOLUNTARILY. I UNDERSTAND THAT THIS AGREEMENT IS A LEGAL
DOCUMENT. 
  

					
	  	 		 	  

  
 5 

 EXHIBIT B 

FleetMatics USA, Inc. 
 Employee Non-Competition, Confidentiality and Assignment Agreement 
 In
consideration and as a material condition of my employment by FleetMatics USA, Inc., a subsidiary of FleetMatics Group Limited (collectively the “Company”), I agree as follows: 

 

 1. Proprietary Information. I agree that all information, whether or not in
writing, concerning the Company’s business, technology, business relationships or financial affairs which the Company has not released to the general public (collectively, “Proprietary Information”) is and will be the exclusive
property of the Company. By way of illustration, Proprietary Information may include information or material which has not been made generally available to the public, such as: (a) corporate information, including plans, strategies,
methods, policies, resolutions, negotiations or litigation; (b) marketing information, including strategies, methods, customer identities or other information about customers, prospect identities or other information about prospects, or
market analyses or projections; (c) financial information, including cost and performance data, debt arrangements, equity structure, investors and holdings, purchasing and sales data and price lists; and (d) operational and
technological information, including plans, specifications, manuals, forms, templates, software, designs, methods, procedures, formulas, discoveries, inventions, improvements, concepts and ideas; and (e) personnel information,
including personnel lists, reporting or organizational structure, resumes, personnel data, compensation structure, performance evaluations and termination arrangements or documents. Proprietary Information also includes information received in
confidence by the Company from its customers or suppliers or other third parties. 
 2. Recognition of Company’s
Rights. I will not, at any time, without the Company’s prior written permission, either during or after my employment, disclose any Proprietary Information to anyone outside of the Company, or use or permit to be used any Proprietary
Information for any purpose other than in connection with the performance of my duties as an employee of the Company. I will cooperate with the Company and use my best efforts to prevent the unauthorized disclosure of all Proprietary Information. I
will deliver to the Company all copies of Proprietary Information in my possession or control upon the earlier of a request by the Company or termination of my employment. 
 3. Rights of Others. I understand that the Company is now and may hereafter be subject to non-disclosure or confidentiality agreements with third persons which require the Company to protect
or refrain from use of proprietary information. I agree to be bound by the terms of such of those agreements as to which I have knowledge in the event I have access to such proprietary information. 

4. Commitment to Company; Avoidance of Conflict of Interest. Subject to the express terms of my employment agreement with
the Company, while an employee of the Company, I will devote my full-time efforts to the

 
Company’s business and I will not engage in any other business activity that conflicts with my duties to the Company. I will advise the president of the Company or his or her nominee at such
time as any activity of either the Company or another business presents me with a conflict of interest or the appearance of a conflict of interest as an employee of the Company. I will take whatever action is requested of me by the Company to
resolve any conflict or appearance of conflict which it finds to exist. 
 5. Developments. I will make full and
prompt disclosure to the Company of all inventions, discoveries, designs, developments, methods, modifications, improvements, processes, algorithms, databases, computer programs, formulae, techniques, trade secrets, graphics or images, and audio or
visual works and other works of authorship related to the business of the Company (collectively “Developments”), whether or not patentable or copyrightable, that are created, made, conceived or reduced to practice by me (alone or jointly
with others) or under my direction during the period of my employment. I acknowledge that all work performed by me for the Company is on a “work for hire” basis, and I hereby do assign and transfer and, to the extent any such assignment
cannot be made at present, will assign and transfer, to the Company and its successors and assigns all my right, title and interest in all Developments made, conceived or reduced to practice by me (alone or jointly with others) that (a) relate
to the business of the Company or any customer of or supplier to the Company or any of the products or services being researched, developed, manufactured or sold by the Company or which may be used with such products or services; or (b) result
from tasks assigned to me by the Company; or (c) result from the use of premises or personal property (whether tangible or intangible) owned, leased or contracted for by the Company (“Company-Related Developments”), and all related
patents, patent applications, trademarks and trademark applications, copyrights and copyright applications, and other intellectual property rights in all countries and territories worldwide and under any international conventions (“Intellectual
Property Rights”). 
 To preclude any possible uncertainty, I have set forth on Exhibit 1 attached hereto a complete list of
Developments that I have, alone or jointly with others, conceived, developed or reduced to practice prior to the commencement of my employment with the Company that I consider to be my property or the property of third parties and that I wish to
have excluded from the scope of this Agreement (“Prior Inventions”). If disclosure of any such Prior Invention would cause me to violate any prior confidentiality agreement, I understand that I am not to list such Prior Inventions in
Exhibit 1 but am only to disclose a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to such inventions has not been

 

 
made for that reason. I have also listed on Exhibit A all patents and patent applications in which I am named as an inventor, other than those which have been assigned to the Company
(“Other Patent Rights”). If no such disclosure is attached, I represent that there are no Prior Inventions or Other Patent Rights. If, in the course of my employment with the Company, I incorporate a Prior Invention into a Company product,
process or machine or other work done for the Company, I hereby grant to the Company a nonexclusive, royalty-free, paid-up, irrevocable, worldwide license (with the full right to sublicense) to make, have made, modify, use, sell, offer for sale and
import such Prior Invention. Notwithstanding the foregoing, I will not incorporate, or permit to be incorporated, Prior Inventions in any Company-Related Development without the Company’s prior written consent. 

This Agreement does not obligate me to assign to the Company any Development which, in the sole judgment of the Company, reasonably exercised, is
developed entirely on my own time and does not relate to the business efforts or research and development efforts in which, during the period of my employment, the Company actually is engaged or reasonably would be engaged, and does not result from
the use of premises or equipment owned or leased by the Company. However, I will also promptly disclose to the Company any such Developments for the purpose of determining whether they qualify for such exclusion. I understand that to the extent this
Agreement is required to be construed in accordance with the laws of any state which precludes a requirement in an employee agreement to assign certain classes of inventions made by an employee, this paragraph 5 will be interpreted not to apply to
any invention which a court rules and/or the Company agrees falls within such classes. I also hereby waive all claims to any moral rights or other special rights which I may have or accrue in any Company-Related Developments. 

6. Documents and Other Materials. I will keep and maintain adequate and current records of all Proprietary Information
and Company-Related Developments developed by me during my employment, which records will be available to and remain the sole property of the Company at all times. 
 All files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks, layouts, charts, quotations and proposals, specification sheets, program listings, blueprints, models,
prototypes, or other written, photographic or other tangible material containing Proprietary Information, whether created by me or others, which come into my custody or possession, are the exclusive property of the Company to be used by me only in
the performance of my duties for the Company. Any property situated on the Company’s premises and owned by the Company, including without limitation computers, disks and other storage media, filing cabinets or other work areas, is subject to
inspection by the Company at any time with or without notice. In the event of the termination of my employment for any reason, I will deliver to the Company all files, letters, notes, memoranda, reports, records, data, sketches, drawings, notebooks,
layouts, charts, quotations and proposals, specification sheets, program

 
listings, blueprints, models, prototypes, or other written, photographic or other tangible material containing Proprietary Information, and other materials of any nature pertaining to the
Proprietary Information of the Company and to my work, and will not take or keep in my possession any of the foregoing or any copies. 
 7. Enforcement of Intellectual Property Rights. I will cooperate fully with the Company, both during and after my employment with the Company, with respect to the procurement, maintenance
and enforcement of Intellectual Property Rights in Company-Related Developments. I will sign, both during and after the term of this Agreement, all papers, including without limitation copyright applications, patent applications, declarations,
oaths, assignments of priority rights, and powers of attorney, which the Company may deem necessary or desirable in order to protect its rights and interests in any Company-Related Development. If the Company is unable, after reasonable effort, to
secure my signature on any such papers, I hereby irrevocably designate and appoint each officer of the Company as my agent and attorney-in-fact to execute any such papers on my behalf, and to take any and all actions as the Company may deem
necessary or desirable in order to protect its rights and interests in any Company-Related Development. 
 8.
Non-Competition and Non-Solicitation. In order to protect the Company’s Proprietary Information and good will, during my employment and for a period of twelve (12) months following the termination of my employment for any
reason (the “Restricted Period”), I will not directly or indirectly, whether as owner, partner, shareholder, director, manager, consultant, agent, employee, co-venturer or otherwise, engage, participate or invest in any business activity
anywhere in the United States that (i) is engaged in the sale, installation or distribution of GPS Vehicle Tracking Systems then engaged in by the Company, and/or (ii) develops, manufactures or markets any products, or performs any
services, that are otherwise competitive with the products or services of the Company, or products or services that the Company or its affiliates, has under development or that are the subject of active planning at any time during my employment
(8(i) and (ii) shall be referred to as the “Company’s Business”); provided that this shall not prohibit any possible investment in publicly traded stock of a company representing less than one percent of the stock of such
company. In addition, during the Restricted Period, I will not, directly or indirectly, in any manner, other than for the benefit of the Company, (a) call upon, solicit, divert, take away, accept or conduct any business from or with any of the
customers or prospective customers of the Company or any of its suppliers if such activities in competition with the Company’s Business, and/or (b) solicit, entice, attempt to persuade any other employee or consultant of the Company to
leave the Company for any reason or otherwise participate in or facilitate the hire, directly or through another entity, of any person who is employed or engaged by the Company or who was employed or engaged by the Company within six months of any
attempt to hire such person. I acknowledge and agree that if I violate any of the provisions of this paragraph 8, the running of the Restricted Period will be extended by the time

 

  
 2 

 
during which I engage in such violation(s). For purposes of this Agreement, a “prospective customer” means any potential customer of the Company which I knew or reasonably should have
known that the Company was actively soliciting (other than through a general campaign) or actively considered soliciting (other than through a general campaign) at any time within the twelve (12) calendar months prior to the last day of my
employment. 
 9. Prior Agreements. I hereby represent that, except as I have fully disclosed previously in
writing to the Company, I am not bound by the terms of any agreement with any previous employer other than SageQuest, Inc. and its subsidiary or other party to refrain from using or disclosing any trade secret or confidential or proprietary
information in the course of my employment with the Company or to refrain from competing, directly or indirectly, with the business of such previous employer or any other party. I further represent that my performance of all the terms of this
Agreement as an employee of the Company does not and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired by me in confidence or in trust prior to my employment with the Company. I will not disclose
to the Company or induce the Company to use any confidential or proprietary information or material belonging to any previous employer or others. 
 10. Remedies Upon Breach. I understand that the restrictions contained in this Agreement are necessary for the protection of the business and goodwill of the Company and I consider them to
be reasonable for such purpose. Any breach of this Agreement is likely to cause the Company substantial and irrevocable damage and therefore, in the event of such breach, the Company, in addition to such other remedies which may be available, will
be entitled to specific performance and other injunctive relief, without the posting of a bond. If I violate this Agreement, in addition to all other remedies available to the Company at law, in equity, and under contract, I agree that I am
obligated to pay all the Company’s costs of enforcement of this Agreement, including attorneys’ fees and expenses. 

11. Use of Voice, Image and Likeness. I give the Company permission to use any and all of my voice, image and likeness,
with or without using my name, in connection with the products and/or services of the Company, for the purposes of advertising and promoting such products and/or services and/or the Company, and/or for other purposes deemed appropriate by the
Company in its reasonable discretion, except to the extent expressly prohibited by law. 
 12. Publications and Public
Statements. I will obtain the Company’s written approval before publishing or submitting for publication any material that relates to my work at the Company and/or incorporates any Proprietary Information. To ensure that the Company
delivers a consistent message about its products, services and operations to the public, and further in recognition that even positive statements may have a detrimental effect on the Company in certain securities transactions and other contexts, any
statement about the Company which I create, publish or post

 
during my period of employment and for six (6) months thereafter, on any media accessible by the public, including but not limited to electronic bulletin boards and Internet-based chat
rooms, must first be reviewed and approved by an officer of the Company before it is released in the public domain. 
 13.
No Employment Obligation. I understand that this Agreement does not create an obligation on the Company or any other person to continue my employment. I acknowledge that, unless otherwise agreed in a formal written employment agreement
signed on behalf of the Company by an authorized officer, my employment with the Company is at will and therefore may be terminated by the Company or me at any time and for any reason, with or without cause. 

14. Survival and Assignment by the Company. I understand that my obligations under this Agreement will continue in
accordance with its express terms regardless of any changes in my title, position, duties, salary, compensation or benefits or other terms and conditions of employment. I further understand that my obligations under this Agreement will continue
following the termination of my employment regardless of the manner of such termination and will be binding upon my heirs, executors and administrators. The Company will have the right to assign this Agreement to its affiliates, successors and
assigns. I expressly consent to be bound by the provisions of this Agreement for the benefit of the Company or any parent, subsidiary or affiliate to whose employ I may be transferred or successor who assumes my employment agreement with the Company
without the necessity that this Agreement be resigned at the time of such transfer or assumption. 
 15. Exit
Interview. If and when I depart from the Company, I may be required to attend an exit interview and sign an “Employee Exit Acknowledgement” to reaffirm my acceptance and acknowledgement of the obligations set forth in this
Agreement. For twelve (12) months following termination of my employment, I will notify the Company of any change in my address and of each subsequent employment or business activity, including the name and address of my employer or other
post-Company employment plans and the nature of my activities. 
 16. Disclosure to Future Employers. During the
Restricted Period, I will provide a copy of this Agreement to any prospective employer, partner or coventurer prior to entering into an employment, partnership or other business relationship with such person or entity. 

17. Severability. In case any provisions (or portions thereof) contained in this Agreement shall, for any reason, be held
invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect the other provisions of this Agreement, and this Agreement shall be construed as if such invalid, illegal or unenforceable provision
had never been contained herein. If, moreover, any one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed by
limiting and reducing it, so as to be enforceable to the extent compatible with the applicable law as it shall then appear.

 

  
 3 

 
 18. Interpretation. This Agreement will be deemed to be made and entered
into in the Commonwealth of Massachusetts, and will in all respects be interpreted, enforced and governed under the laws of the Commonwealth of Massachusetts. I hereby agree to consent to personal jurisdiction of the state and federal courts
situated within Suffolk County, Massachusetts for purposes of enforcing this Agreement, and waive any objection that I might have to personal jurisdiction or venue in those courts.

 
 

  
 4 

 I UNDERSTAND THAT THIS AGREEMENT AFFECTS IMPORTANT RIGHTS. BY SIGNING BELOW, I CERTIFY
THAT I HAVE READ IT CAREFULLY AND AM SATISFIED THAT I UNDERSTAND IT COMPLETELY. 
 IN WITNESS WHEREOF, the undersigned has
executed this agreement as a sealed instrument as of the date set forth below. 
  

			
	Signed:	 	  

			
		
	Type or print name:	 	  

			
		
	Date:	 	  

 EXHIBIT 1 
 To:       FleetMatics USA, Inc. 
 From:
                     
 Date:
                     

SUBJECT:  Prior Inventions 
 The following is a complete list of all inventions or improvements relevant to the subject matter of my employment by the Company that have been made or conceived or first reduced to practice by me alone
or jointly with others prior to my engagement by the Company: 
 No inventions or improvements 

See below: 
  

	
	  

	
	  

	
	  

 Additional sheets attached 
 The following is a list of all patents and patent applications in which I have been named as an inventor: 
 None 
 See below: 

 

	
	  

	
	  

	
	  

  
 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}]]